Neurocrine Biosciences to Present at Upcoming Investor Conferences in September

Key Facts

2023 Wells Fargo Healthcare Conference on September 7 in Boston Morgan Stanley 21st Annual Global Healthcare Conference on September 12 in New York , /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at two upcoming investor conferences in September.
Kyle Gano, Chief Business Development and Strategy Officer, and Todd Tushla, Vice President of Investor Relations, will present at the 2023 Wells Fargo Healthcare Conference at 3:45 p.m.
Kevin Gorman, Chief Executive Officer, and Matt Abernethy, Chief Financial Officer, will present at the Morgan Stanley 21st Annual Global Healthcare Conference at 10:50 a.m.
A replay of the presentations will be available on the website approximately one hour after the conclusion of the event and will be archived for approximately one month.